FDX1 and hepatocellular carcinoma: Similarly, key molecules of cuproptosis, such as FDX1 and DLAT, have been shown to function as tumor suppressors in GI tumors like HCC, and activating this pathway can significantly reduce tumor cell viability [21, 105].